Inventor · disambiguated record
Nicholas Robert Perl
Also filed as: PERL NICHOLAS · PERL NICHOLAS ROBERT
6 granted patents·10 pending applications·26 citations·filing 2009–2024
80Inventor score
Files withRIBON THERAPEUTICS INC9REVOLUTION MEDICINES INC4BOEHRINGER INGELHEIM INT1GIN DAVID1GIN DAVID Y1
Top patents by PatentIndex Score
16 records- 0193US11535621B2Heterobicyclic amides as inhibitors of CD38RIBON THERAPEUTICS INC·Filed 2020·Granted Dec 27, 2022·3 cites·4 claims
- 0292US11987584B2Heterobicyclic amides as inhibitors of CD38RIBON THERAPEUTICS INC·Filed 2022·Granted May 21, 2024·1 cites·22 claims
- 0386US8283456B2Triterpene saponins, methods of synthesis, and uses thereofGIN DAVID·Filed 2009·Granted Oct 9, 2012·12 cites·16 claims
- 0485US11691969B2Pyridazinones as PARP7 inhibtorsRIBON THERAPEUTICS INC·Filed 2020·Granted Jul 4, 2023·1 cites·75 claims
- 0583US12398146B2Heterobicyclic amides as inhibitors of CD38BOEHRINGER INGELHEIM INT·Filed 2024·Granted Aug 26, 2025·0 cites·53 claims
- 0682US8889842B2Triterpene saponins, methods of synthesis, and uses thereofGIN DAVID Y·Filed 2012·Granted Nov 18, 2014·9 cites·13 claims
- 0776US2025074897A1Pyridazinones as parp7 inhibitorsRIBON THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0875US2024426833A1Methods and reagents for analyzing protein-protein interfacesREVOLUTION MEDICINES INC·Filed 2024·Application pending·0 cites
- 0972US2024034728A1Pyridazinones as parp7 inhibitorsRIBON THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1071US2024139185A1Compounds that participate in cooperative binding and uses thereofREVOLUTION MEDICINES INC·Filed 2023·Application pending·0 cites
- 1165US2024051946A1Targeted protein degradation of parp14 for use in therapyRIBON THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1263US2024101540A1Targeted protein degradation of parp14 for use in therapyRIBON THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1362US2020197391A1Compounds that participate in cooperative binding and uses thereofREVOLUTION MEDICINES INC·Filed 2019·Application pending·0 cites
- 1461US2024190844A1Pyridazinones as parp7 inhibitorsRIBON THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1561US2023303542A1Solid forms of a parp14 inhibitorRIBON THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1655US2021285955A1Methods and reagents for analyzing protein-protein interfacesREVOLUTION MEDICINES INC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Nicholas Robert Perl files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →